SWX: BIOV

Company Deals

BioVersys Partners with Shionogi to Advance BV500 for Non-Tuberculous Mycobacterial Infections

Fineline Cube Jul 4, 2025

Swiss biopharma BioVersys AG (SWX: BIOV) announced a research and exclusive license option agreement with...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod